The event, organized by the Middlesex County Office of Health Services, aims to raise awareness and funds for pancreatic ...
(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...
Immuneering Corporation upgraded to Strong Buy after positive phase 2a data in pancreatic cancer. Click here to find out why ...
For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...
A Cornell-led study has revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing ...
Pancreatic cancer forms in the tissues of the pancreas, often in the cells lining the ducts (pancreatic ductal adenocarcinoma ...
Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on ...
The Chosun Ilbo on MSN
Pancreatic cancer tumor disappears with combined immune cell and drug therapy
Pancreatic cancer tumor disappears with combined immune cell and drug therapy Konyang University Hospital reports significant ...
A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types ...
New platform offers vital peer-to-peer support, shared experiences, and practical knowledge for those affected by pancreatic ...
Truist analysts called the results "encouraging" while pointing out certain unknowns in the data. Immuneering plans to kick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback